A reduced induction of AMPs such as hBD-2 and cathelicidin, in conjunction with defects in the epidermal barrier in AD, contributes to the increased susceptibility of AD skin to S. aureus infection [2, 25, 26]. The gene discussed is ADSL; the disease is Alzheimer disease.